$RGBP About Regen BioPharma Inc.: Regen BioPha
Post# of 47038
Regen BioPharma Inc. is a publicly traded biotechnology company (RGBP) and (RGBPP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on gene silencing therapy and small molecule therapies for treating cancer, along with developing stem cell treatments for aplastic anemia and disorders of the bone marrow. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
https://finance.yahoo.com/news/regen-biopharm...00232.html